CD40LG and myeloid sarcoma: In patients with clinically isolated syndrome (CIS), IgM OCB detection was associated with higher risks of conversion to clinically definite MS and in relapsing–remitting (RRMS) patients predicted a higher probability of converting to secondary progressive MS (Villar et al., 2002).